FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069265 [Registered on: 20/06/2024] Trial Registered Prospectively
Last Modified On: 20/05/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   Clinical Evaluation of Siddha Medicine Soosika Chooranam for Soothaga Vaayu (PCOD) 
Scientific Title of Study   Single Centric Non Randomized Open Clinical trial Phase II in Soothaga Vaayu (PCOD) with Siddha Medicine Soosika Chooranam among patients attending OPD at Government Siddha Medical College Hospital, Chennai. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr G Sanjana  
Designation  PG Scholar 
Affiliation  Government Siddha Medical College,Chennai. 
Address  Department of Pothu Maruthuvam, Government Siddha Medical College,Arumbakkam,Chennai.

Chennai
TAMIL NADU
600106
India 
Phone  8939311792  
Fax    
Email  sanjugopi1997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr U Chithra 
Designation  Lecturer, Department of PG Pothu Maruthuvam 
Affiliation  Government Siddha Medical College,Chen 
Address  Department of Pothu Maruthuvam, Government Siddha Medical College,Arumbakkam,Chennai.

Chennai
TAMIL NADU
600106
India 
Phone  9445716802  
Fax    
Email  mmsankar2000@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr U Chithra 
Designation  Lecturer, Department of PG Pothu Maruthuvam 
Affiliation  Government Siddha Medical College,Chen 
Address  Department of Pothu Maruthuvam, Government Siddha Medical College,Arumbakkam,Chennai.

Chennai
TAMIL NADU
600106
India 
Phone  9445716802  
Fax    
Email  mmsankar2000@gmail.com  
 
Source of Monetary or Material Support  
Government Siddha Medical College, No-6, Anna Arch Road,Arumbakkam, Chennai - 600106. 
 
Primary Sponsor  
Name  Government Siddha Medical College, Chennai 
Address  No-6, Anna Arch Road, Arumbakkam, Chennai - 600106 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr G Sanjana  Government Siddha Medical College, Chennai.  Department of PG Pothu Maruthuvam, Room No. S1, Government Siddha Medical College Hospital, Arumbakkam, Chennai 600106.
Chennai
TAMIL NADU 
8939311792

sanjugopi1997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee, Arumbakkam, Chennai.   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N948||Other specified conditions associated with female genital organs and menstrual cycle,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
Intervention  Soosika Chooranam  The medicine will be given 2gms twice a day for 40 days with Adjuvants(Paccharisi Kazhuneer - 1-10 days,Muthakasu kudineer -11 - 20 days, Puliyatha pasumor -21 - 30 davs Elavenneer - 31 - 40 days. Total : 40 days (For 3 consecutive menstrual cycles) 
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  a.Female aged between 15-45 years (24).
b. Based upon the presence of any two of the following Rotterdam criteria
1.Oligo / Anovulation
2.Hyperandrogenism (Clinical/Biochemical)
3.Polycystic ovaries (unilateral/bilateral)
c. Seeking treatment for PCOD induced infertility 
 
ExclusionCriteria 
Details  Under any other serious systemic illness. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Regulation of menstrual cycle and harmonal profile.  3 months 
 
Secondary Outcome  
Outcome  TimePoints 
Disappearance/reduction in the size or number of cysts.  3 months 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   02/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) -  NIL

  6. For how long will this data be available start date provided 05-06-2025 and end date provided 31-12-2026?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  
PCOD is a multifactorial and polygenic condition, manifested by amenorrhea, hirsutism and obesity associated with enlarged polycystic ovaries.This complex endocrine disorder occurs at a frequency of 11.2% in women of reproductive age group.It was first described by Stein and Leventhal in 1935 and is linked with anovulation. It is now recognized as a common, heterogeneous heritable disorder affecting women throughout their lifetime. In Siddha system of Medicine, there are unique combinations of medicines which have solutions to the present scenario of PCOD. One such combination is SOOSIKA CHOORANAM which will be more effective and reliable. The method of preparation of the medicine is easy and the raw drugs are also easily available.

 
Close